Insight

William Aird: Nice retrospective single center cohort on Secondary Polycythemia

Photo from William Aird/X

Jul 26, 2024, 14:28

William Aird: Nice retrospective single center cohort on Secondary Polycythemia

William Aird, Professor of Medicine at Harvard Medical School, shared a post on X:

“Secondary Polycythemia.

Nice little retrospective single center (my alma mater) cohort study of Jak2-mutation-negative patients with elevated Hb.

Some of the usual causes and additional evidence for a possible association with use of SGLT2 inhibitors.”

Source: William Aird/X

cancer elevated Hb Harvard Medical School Jak2-mutation-negative patients OncoDaily Oncology Secondary Polycythemia SGLT2 inhibitors single center cohort William Aird

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Voices

Aug 22, 2025, 18:29

Wee Joo Chng: Kicking Off NUS Medicine’s Inspire120 Professorial Lecture Series

Science

Aug 22, 2025, 18:13

George Kumar Shares Research Showing Respiratory Viruses Awaken Dormant Breast Cancer Cells

Voices

Aug 22, 2025, 17:57

Hil Moss: What's New in Cancer Survivorship?

Insight

Aug 22, 2025, 17:44

Kefah Mokbel Shares New Insights on Metaplastic Breast Cancer Survival

Insight

Aug 22, 2025, 17:37

Salvador Jaime-Casas: Predicting Occult Lymph Node Involvement in Bladder Cancer

Positive

Aug 22, 2025, 17:31

More Lives Touched, More Hope Delivered: Supporting Patients in Lesotho - The Max Foundation

Voices

Aug 22, 2025, 17:20

Nominations for the 20th NSW Premier’s Awards for Outstanding Cancer Research Are Closing Soon

Insight

Aug 22, 2025, 17:10

Ravi Parikh: Performance Drift in a National Population Health Risk Algorithm

Voices

Aug 22, 2025, 16:46

Pauline Ryan: Empowering Cancer Leaders Through Lived Experience Program

Voices

Aug 22, 2025, 16:15

Maria Tolia Highlights Tool to Predict Additional Positive Non-SLN in Breast Cancer

Immune Oncology

Aug 22, 2025, 16:07

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

Voices

Aug 22, 2025, 16:06

Rob Winn: How Are You Reimagining Navigation to Help Patients Access and Stay Engaged in Their Care?